JGC
BDSI

J. Goldman & Co’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

J. Goldman & Co’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-210,000
Closed -$2.21M – 401
2015
Q1 		$2.21M Buy
+210,000
New +$2.87M 0.14% 176

Other funds holding BDSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

J. Goldman & Co's BDSI Position: Q2 2020 in Review

J. Goldman & Co sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2020, closing a stake of 115,550 shares — an estimated $438K sold.

J. Goldman & Co first reported a position in BDSI in Q3 2017 and held it in 5 quarters. The position peaked at $2.1M in Q3 2019. 158 funds tracked by Wall St. Rank hold BDSI as of Q2 2020.

  • J. Goldman & Co reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2020 after selling out during the quarter.
  • J. Goldman & Co sold 115,550 BioDelivery Sciences International, Inc. shares in Q2 2020, an estimated $438K.
  • J. Goldman & Co first reported a position in BioDelivery Sciences International, Inc. in Q3 2017 and held it in 5 quarters.
  • J. Goldman & Co's BioDelivery Sciences International, Inc. position peaked at $2.1M in Q3 2019.
  • 158 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2020.

Based on J. Goldman & Co's 13F filing for Q2 2020, filed 14 Aug 2020.